NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via miR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib.

MLA

Hou, Sheng-Mou, et al. “NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via MiR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib.” Life (2075-1729), vol. 15, no. 1, Jan. 2025, p. 99. EBSCOhost, https://doi.org/10.3390/life15010099.

APA

Hou, S.-M., Cheng, C.-Y., Chen, W.-L., Chang, E.-M., & Lin, C.-Y. (2025). NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via miR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib. Life (2075-1729), 15(1), 99. https://doi.org/10.3390/life15010099

Chicago

Hou, Sheng-Mou, Ching-Yuan Cheng, Wei-Li Chen, En-Ming Chang, and Chih-Yang Lin. 2025. “NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via MiR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib.” Life (2075-1729) 15 (1): 99. doi:10.3390/life15010099.